Danaher Corp (NY:DHR)

218.18 +4.12 (+1.92%)

Delayed Quote Updated: 12:03 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

29 30 Next >

Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating ↗

October 22, 2024

Danaher posts Q3 sales of $5.79 billion, surpassing expectations. 2024 guidance includes bioprocessing revenue decline and Cepheid respiratory sales of $1.7 billion.

Via Benzinga

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday? ↗

October 22, 2024

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election just two weeks away. Concerns over U.S. fiscal policies and...

Via Benzinga

A Closer Look at Danaher's Options Market Dynamics ↗

October 22, 2024

Via Benzinga

Earnings Preview: Danaher ↗

October 21, 2024

Via Benzinga

This Is What Whales Are Betting On Danaher ↗

October 16, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

October 14, 2024

Via Benzinga

Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To Annual Guidance ↗

October 22, 2024

Danaher posted third-quarter sales of $5.8 billion, surpassing expectations, with growth in life sciences and diagnostics segments, and a 27.5% operating margin.

Via Benzinga

Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential' ↗

October 18, 2024

Hedge fund manager Daniel Loeb is optimistic about the economy and market and he sees Trump likely retaking White House.

Via Benzinga

Topics Economy Government

Uncovering Noteworthy Technical Analysis Findings for DANAHER CORP (NYSE:DHR). ↗

October 16, 2024

The technical analysis for DANAHER CORP (NYSE:DHR) is highly positive, with a rating of 8 out of 10, suggesting a potential breakout.

Via Chartmill

Looking Into Danaher's Recent Short Interest ↗

October 04, 2024

Via Benzinga

Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers. ↗

October 03, 2024

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Via Investor's Business Daily

Topics Stocks

DANAHER CORP (NYSE:DHR) can be considered a quality stock. Here's why. ↗

October 01, 2024

Why Quality Investors May Find DANAHER CORP (NYSE:DHR) Attractive.

Via Chartmill

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today ↗

September 27, 2024

Via Benzinga

Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst ↗

October 01, 2024

Stifel analyst Jacob Johnson says Danaher is poised for a gradual recovery in 2025 and could generate high-single-digit growth.

Via Benzinga

Spotlight on Danaher: Analyzing the Surge in Options Activity ↗

September 26, 2024

Via Benzinga

Danaher Unusual Options Activity ↗

September 23, 2024

Via Benzinga

Momentum Investing Gives You An Edge, Until It Doesn’t ↗

September 17, 2024

Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.

Via Talk Markets

Unpacking the Latest Options Trading Trends in Danaher ↗

September 09, 2024

Via Benzinga

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today ↗

September 06, 2024

Via Benzinga

Smart Money Is Betting Big In DHR Options ↗

September 05, 2024

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today ↗

August 26, 2024

Via Benzinga

Behind the Scenes of Danaher's Latest Options Trends ↗

August 05, 2024

Via Benzinga

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today ↗

August 02, 2024

Via Benzinga

Agilent Technologies Thrives From the Forever Chemicals Crackdown

September 05, 2024

Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets.

Via MarketBeat

The Defensive Sectors And VIX Have NOT Given The All-Clear Signal ↗

August 08, 2024

The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture.

Via Talk Markets

Topics Stocks

10 Health Care Stocks Whale Activity In Today's Session ↗

August 08, 2024

Via Benzinga

(DHR) - Analyzing Danaher's Short Interest ↗

August 01, 2024

Via Benzinga

Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount' ↗

July 30, 2024

Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."

Via Benzinga

Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease

July 30, 2024

From Biogen Inc.

Via GlobeNewswire

Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio? ↗

July 28, 2024

11 large-cap stocks saw significant gains in the last week, driven by positive earnings and guidance updates. Check if they're in your portfolio.

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.